For a menopause-related search, choose a source category below. These categories also contain products for other uses; they are not a list of suitable treatments.
HORMONES AND SUBSTITUTES
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
DESOGESTREL & ETHINYL ESTRADIOL: products 1 to 12 of 12.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Apri 21 0.15mg & 0.03mg Tab-21 PkDIN 02317192 | General benefit | $5.2773per source unit | Requirements & sourcesBuild cost plan |
| Apri 28 0.15mg & 0.03mg Tab-28 PkDIN 02317206 | General benefit | $5.2780per source unit | Requirements & sourcesBuild cost plan |
| Freya 21 0.15mg & 0.03mg Tab-21 PkDIN 02396491 | General benefit | $5.2773per source unit | Requirements & sourcesBuild cost plan |
| Freya 28 0.15mg & 0.03mg Tab-28 PkDIN 02396610 | General benefit | $5.2780per source unit | Requirements & sourcesBuild cost plan |
| Linessa 21 3 Phase Tabs-21 PkDIN 02272903 | General benefit | $20.2500per source unit | Requirements & sourcesBuild cost plan |
| Linessa 28 3 Phase Tabs-28 PkDIN 02257238 | General benefit | $20.2500per source unit | Requirements & sourcesBuild cost plan |
| Marvelon 21 0.15mg & 0.03mg Tab-21 PkDIN 02042487 | General benefit | $5.2773per source unit | Requirements & sourcesBuild cost plan |
| Marvelon 28 0.15mg & 0.03mg Tab-28 PkDIN 02042479 | General benefit | $5.2780per source unit | Requirements & sourcesBuild cost plan |
| Miley 21 0.15mg & 0.03mg Tab-21 PkDIN 02556553 | General benefit | $5.2773per source unit | Requirements & sourcesBuild cost plan |
| Miley 28 0.15mg & 0.03mg Tab-28 PkDIN 02556561 | General benefit | $5.2780per source unit | Requirements & sourcesBuild cost plan |
| Mirvala 21 0.15mg & 0.03mg Tab-21 PkDIN 02410249 | General benefit | $5.2773per source unit | Requirements & sourcesBuild cost plan |
| Mirvala 28 0.15mg & 0.03mg Tab-28 PkDIN 02410257 | General benefit | $5.2780per source unit | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
68:00 HORMONES AND SUBSTITUTES.
68:04 Corticosteroids.
68:08 Androgens.
68:12 Contraceptives.
68:16 Estrogens.
68:20:02 Oral Anti-Diabetic Agents.
68:20:06 Incretin Mimetics.
68:20:10 Insulins (Rapid Acting).
68:20:12 Insulins (Intermediate Acting).
68:20:14 Insulins (Long Acting).
68:20:16 Insulins (Pre-Mixed).
68:24 Parathyroid Agents.
68:28 Pituitary Agents.
68:32 Progestogens and Oral Contraceptives.
68:36 Thyroids.
68:38 Anti-Thyroids.
National Defence, WDH Guide to Menopause, 2026-09-17
Hormone Therapy (HT) previously called Hormone Replacement Therapy replaces estrogen and when needed, progesterone
Ontario Drug Benefit Formulary, Part V, 2026-09-03, p. 38
68:16 Estrogens
68:32 Progestogens and Oral Contraceptives